nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—psoriasis—ankylosing spondylitis	0.155	1	CtDrD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—ankylosing spondylitis	0.0558	0.178	CiPCiCtD
Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.0551	0.254	CrCtD
Fluocinonide—Dexamethasone—ankylosing spondylitis	0.0542	0.25	CrCtD
Fluocinonide—Betamethasone—ankylosing spondylitis	0.0542	0.25	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—ankylosing spondylitis	0.0537	0.172	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—ankylosing spondylitis	0.0537	0.172	CiPCiCtD
Fluocinonide—Triamcinolone—ankylosing spondylitis	0.0529	0.245	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—ankylosing spondylitis	0.0519	0.166	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—ankylosing spondylitis	0.0502	0.161	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—ankylosing spondylitis	0.0474	0.152	CiPCiCtD
Fluocinonide—SERPINA6—Triamcinolone—ankylosing spondylitis	0.0287	0.231	CbGbCtD
Fluocinonide—SERPINA6—Prednisolone—ankylosing spondylitis	0.0243	0.195	CbGbCtD
Fluocinonide—NR3C1—Methylprednisolone—ankylosing spondylitis	0.0177	0.142	CbGbCtD
Fluocinonide—NR3C1—Triamcinolone—ankylosing spondylitis	0.0134	0.108	CbGbCtD
Fluocinonide—NR3C1—Betamethasone—ankylosing spondylitis	0.0115	0.0925	CbGbCtD
Fluocinonide—NR3C1—Prednisolone—ankylosing spondylitis	0.0114	0.0913	CbGbCtD
Fluocinonide—NR3C1—Prednisone—ankylosing spondylitis	0.0107	0.0862	CbGbCtD
Fluocinonide—NR3C1—Dexamethasone—ankylosing spondylitis	0.00669	0.0538	CbGbCtD
Fluocinonide—Ciclesonide—Methylprednisolone—ankylosing spondylitis	0.00172	0.0105	CrCrCtD
Fluocinonide—Fluticasone furoate—Dexamethasone—ankylosing spondylitis	0.00162	0.0099	CrCrCtD
Fluocinonide—Fluticasone furoate—Betamethasone—ankylosing spondylitis	0.00162	0.0099	CrCrCtD
Fluocinonide—Fluticasone furoate—Triamcinolone—ankylosing spondylitis	0.00159	0.00968	CrCrCtD
Fluocinonide—Ciclesonide—Prednisone—ankylosing spondylitis	0.00157	0.00955	CrCrCtD
Fluocinonide—Flurandrenolide—Methylprednisolone—ankylosing spondylitis	0.00153	0.00936	CrCrCtD
Fluocinonide—Ciclesonide—Prednisolone—ankylosing spondylitis	0.00153	0.00932	CrCrCtD
Fluocinonide—Flurandrenolide—Dexamethasone—ankylosing spondylitis	0.00151	0.00921	CrCrCtD
Fluocinonide—Flurandrenolide—Betamethasone—ankylosing spondylitis	0.00151	0.00921	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Methylprednisolone—ankylosing spondylitis	0.00148	0.00904	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Dexamethasone—ankylosing spondylitis	0.00146	0.0089	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Betamethasone—ankylosing spondylitis	0.00146	0.0089	CrCrCtD
Fluocinonide—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.00144	0.00875	CrCrCtD
Fluocinonide—Difluprednate—Methylprednisolone—ankylosing spondylitis	0.00144	0.00875	CrCrCtD
Fluocinonide—Halobetasol Propionate—Methylprednisolone—ankylosing spondylitis	0.00144	0.00875	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Triamcinolone—ankylosing spondylitis	0.00143	0.0087	CrCrCtD
Fluocinonide—Halobetasol Propionate—Dexamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Halobetasol Propionate—Betamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Difluprednate—Betamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Difluprednate—Dexamethasone—ankylosing spondylitis	0.00141	0.00861	CrCrCtD
Fluocinonide—Difluprednate—Triamcinolone—ankylosing spondylitis	0.00138	0.00842	CrCrCtD
Fluocinonide—Halobetasol Propionate—Triamcinolone—ankylosing spondylitis	0.00138	0.00842	CrCrCtD
Fluocinonide—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00138	0.00842	CrCrCtD
Fluocinonide—Flurandrenolide—Prednisolone—ankylosing spondylitis	0.00137	0.00833	CrCrCtD
Fluocinonide—Clocortolone—Methylprednisolone—ankylosing spondylitis	0.00135	0.00823	CrCrCtD
Fluocinonide—Beclomethasone—Betamethasone—ankylosing spondylitis	0.00133	0.0081	CrCrCtD
Fluocinonide—Clocortolone—Dexamethasone—ankylosing spondylitis	0.00133	0.0081	CrCrCtD
Fluocinonide—Clocortolone—Betamethasone—ankylosing spondylitis	0.00133	0.0081	CrCrCtD
Fluocinonide—Beclomethasone—Dexamethasone—ankylosing spondylitis	0.00133	0.0081	CrCrCtD
Fluocinonide—Fluocortolone—Methylprednisolone—ankylosing spondylitis	0.00131	0.00799	CrCrCtD
Fluocinonide—Beclomethasone—Triamcinolone—ankylosing spondylitis	0.0013	0.00791	CrCrCtD
Fluocinonide—Clocortolone—Triamcinolone—ankylosing spondylitis	0.0013	0.00791	CrCrCtD
Fluocinonide—Fluocortolone—Dexamethasone—ankylosing spondylitis	0.00129	0.00787	CrCrCtD
Fluocinonide—Fluocortolone—Betamethasone—ankylosing spondylitis	0.00129	0.00787	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	0.00127	0.00777	CrCrCtD
Fluocinonide—Fluocortolone—Triamcinolone—ankylosing spondylitis	0.00126	0.00769	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	0.00125	0.00765	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	0.00125	0.00765	CrCrCtD
Fluocinonide—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00124	0.00756	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	0.00123	0.00747	CrCrCtD
Fluocinonide—Budesonide—Betamethasone—ankylosing spondylitis	0.00122	0.00744	CrCrCtD
Fluocinonide—Budesonide—Dexamethasone—ankylosing spondylitis	0.00122	0.00744	CrCrCtD
Fluocinonide—Amcinonide—Dexamethasone—ankylosing spondylitis	0.00122	0.00744	CrCrCtD
Fluocinonide—Amcinonide—Betamethasone—ankylosing spondylitis	0.00122	0.00744	CrCrCtD
Fluocinonide—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.00121	0.00737	CrCrCtD
Fluocinonide—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00121	0.00737	CrCrCtD
Fluocinonide—Desonide—Methylprednisolone—ankylosing spondylitis	0.00121	0.00737	CrCrCtD
Fluocinonide—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.00121	0.00737	CrCrCtD
Fluocinonide—Beclomethasone—Prednisolone—ankylosing spondylitis	0.0012	0.00733	CrCrCtD
Fluocinonide—Clocortolone—Prednisolone—ankylosing spondylitis	0.0012	0.00733	CrCrCtD
Fluocinonide—Fluocortolone—Prednisone—ankylosing spondylitis	0.0012	0.00729	CrCrCtD
Fluocinonide—Amcinonide—Triamcinolone—ankylosing spondylitis	0.00119	0.00727	CrCrCtD
Fluocinonide—Budesonide—Triamcinolone—ankylosing spondylitis	0.00119	0.00727	CrCrCtD
Fluocinonide—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Flunisolide—Dexamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Diflorasone—Betamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Flunisolide—Betamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Desonide—Betamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Desonide—Dexamethasone—ankylosing spondylitis	0.00119	0.00725	CrCrCtD
Fluocinonide—Paramethasone—Methylprednisolone—ankylosing spondylitis	0.00118	0.00718	CrCrCtD
Fluocinonide—Fluocortolone—Prednisolone—ankylosing spondylitis	0.00117	0.00712	CrCrCtD
Fluocinonide—Flunisolide—Triamcinolone—ankylosing spondylitis	0.00116	0.00709	CrCrCtD
Fluocinonide—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.00116	0.00709	CrCrCtD
Fluocinonide—Desonide—Triamcinolone—ankylosing spondylitis	0.00116	0.00709	CrCrCtD
Fluocinonide—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00116	0.00709	CrCrCtD
Fluocinonide—Paramethasone—Dexamethasone—ankylosing spondylitis	0.00116	0.00707	CrCrCtD
Fluocinonide—Paramethasone—Betamethasone—ankylosing spondylitis	0.00116	0.00707	CrCrCtD
Fluocinonide—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00115	0.00701	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	0.00114	0.00692	CrCrCtD
Fluocinonide—Paramethasone—Triamcinolone—ankylosing spondylitis	0.00113	0.00691	CrCrCtD
Fluocinonide—Amcinonide—Prednisone—ankylosing spondylitis	0.00113	0.0069	CrCrCtD
Fluocinonide—Budesonide—Prednisone—ankylosing spondylitis	0.00113	0.0069	CrCrCtD
Fluocinonide—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00113	0.0069	CrCrCtD
Fluocinonide—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00113	0.0069	CrCrCtD
Fluocinonide—Mometasone—Methylprednisolone—ankylosing spondylitis	0.00112	0.00684	CrCrCtD
Fluocinonide—Fluorometholone—Methylprednisolone—ankylosing spondylitis	0.00112	0.00684	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Methylprednisolone—ankylosing spondylitis	0.00112	0.00684	CrCrCtD
Fluocinonide—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.00112	0.00684	CrCrCtD
Fluocinonide—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00111	0.00674	CrCrCtD
Fluocinonide—Amcinonide—Prednisolone—ankylosing spondylitis	0.00111	0.00674	CrCrCtD
Fluocinonide—Budesonide—Prednisolone—ankylosing spondylitis	0.00111	0.00674	CrCrCtD
Fluocinonide—Mometasone—Betamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Dexamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Triamcinolone—Betamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Mometasone—Dexamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Fluorometholone—Dexamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Fluorometholone—Betamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Betamethasone—ankylosing spondylitis	0.0011	0.00674	CrCrCtD
Fluocinonide—Desonide—Prednisone—ankylosing spondylitis	0.0011	0.00672	CrCrCtD
Fluocinonide—Diflorasone—Prednisone—ankylosing spondylitis	0.0011	0.00672	CrCrCtD
Fluocinonide—Flunisolide—Prednisone—ankylosing spondylitis	0.0011	0.00672	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.0011	0.00672	CrCrCtD
Fluocinonide—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.0011	0.00669	CrCrCtD
Fluocinonide—Rimexolone—Methylprednisolone—ankylosing spondylitis	0.0011	0.00669	CrCrCtD
Fluocinonide—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.0011	0.00669	CrCrCtD
Fluocinonide—Rimexolone—Dexamethasone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Rimexolone—Betamethasone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Triamcinolone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Fluorometholone—Triamcinolone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Mometasone—Triamcinolone—ankylosing spondylitis	0.00108	0.00658	CrCrCtD
Fluocinonide—Flunisolide—Prednisolone—ankylosing spondylitis	0.00108	0.00656	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.00108	0.00656	CrCrCtD
Fluocinonide—Desonide—Prednisolone—ankylosing spondylitis	0.00108	0.00656	CrCrCtD
Fluocinonide—Diflorasone—Prednisolone—ankylosing spondylitis	0.00108	0.00656	CrCrCtD
Fluocinonide—Paramethasone—Prednisone—ankylosing spondylitis	0.00108	0.00656	CrCrCtD
Fluocinonide—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00105	0.00643	CrCrCtD
Fluocinonide—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00105	0.00643	CrCrCtD
Fluocinonide—Rimexolone—Triamcinolone—ankylosing spondylitis	0.00105	0.00643	CrCrCtD
Fluocinonide—Paramethasone—Prednisolone—ankylosing spondylitis	0.00105	0.0064	CrCrCtD
Fluocinonide—Desoximetasone—Prednisone—ankylosing spondylitis	0.00105	0.0064	CrCrCtD
Fluocinonide—Methylprednisolone—Betamethasone—ankylosing spondylitis	0.00103	0.00629	CrCrCtD
Fluocinonide—Methylprednisolone—Dexamethasone—ankylosing spondylitis	0.00103	0.00629	CrCrCtD
Fluocinonide—Triamcinolone—Prednisone—ankylosing spondylitis	0.00102	0.00625	CrCrCtD
Fluocinonide—Mometasone—Prednisone—ankylosing spondylitis	0.00102	0.00625	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisone—ankylosing spondylitis	0.00102	0.00625	CrCrCtD
Fluocinonide—Fluorometholone—Prednisone—ankylosing spondylitis	0.00102	0.00625	CrCrCtD
Fluocinonide—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00102	0.00624	CrCrCtD
Fluocinonide—Methylprednisolone—Triamcinolone—ankylosing spondylitis	0.00101	0.00615	CrCrCtD
Fluocinonide—Dexamethasone—Prednisone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Rimexolone—Prednisone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Betamethasone—Prednisone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Fluorometholone—Prednisolone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Triamcinolone—Prednisolone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Mometasone—Prednisolone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisolone—ankylosing spondylitis	0.001	0.0061	CrCrCtD
Fluocinonide—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000977	0.00596	CrCrCtD
Fluocinonide—Rimexolone—Prednisolone—ankylosing spondylitis	0.000977	0.00596	CrCrCtD
Fluocinonide—Betamethasone—Prednisolone—ankylosing spondylitis	0.000977	0.00596	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisone—ankylosing spondylitis	0.000957	0.00584	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisolone—ankylosing spondylitis	0.000935	0.0057	CrCrCtD
Fluocinonide—Secondary adrenocortical insufficiency—Prednisone—ankylosing spondylitis	0.000469	0.0171	CcSEcCtD
Fluocinonide—Dermatitis perioral—Triamcinolone—ankylosing spondylitis	0.000454	0.0165	CcSEcCtD
Fluocinonide—Cushing's syndrome—Triamcinolone—ankylosing spondylitis	0.000454	0.0165	CcSEcCtD
Fluocinonide—Dermatitis perioral—Methylprednisolone—ankylosing spondylitis	0.000453	0.0165	CcSEcCtD
Fluocinonide—Telangiectasia—Methylprednisolone—ankylosing spondylitis	0.000436	0.0159	CcSEcCtD
Fluocinonide—Cataract subcapsular—Prednisolone—ankylosing spondylitis	0.000429	0.0156	CcSEcCtD
Fluocinonide—Cushing's syndrome—Dexamethasone—ankylosing spondylitis	0.000412	0.015	CcSEcCtD
Fluocinonide—Dermatitis perioral—Dexamethasone—ankylosing spondylitis	0.000412	0.015	CcSEcCtD
Fluocinonide—Dermatitis perioral—Betamethasone—ankylosing spondylitis	0.000412	0.015	CcSEcCtD
Fluocinonide—Cushing's syndrome—Betamethasone—ankylosing spondylitis	0.000412	0.015	CcSEcCtD
Fluocinonide—Acneiform eruption—Triamcinolone—ankylosing spondylitis	0.000408	0.0148	CcSEcCtD
Fluocinonide—Acneiform eruption—Methylprednisolone—ankylosing spondylitis	0.000407	0.0148	CcSEcCtD
Fluocinonide—Telangiectasia—Dexamethasone—ankylosing spondylitis	0.000397	0.0144	CcSEcCtD
Fluocinonide—Telangiectasia—Betamethasone—ankylosing spondylitis	0.000397	0.0144	CcSEcCtD
Fluocinonide—Cataract subcapsular—Triamcinolone—ankylosing spondylitis	0.000395	0.0144	CcSEcCtD
Fluocinonide—Cataract subcapsular—Methylprednisolone—ankylosing spondylitis	0.000394	0.0143	CcSEcCtD
Fluocinonide—Acneiform eruption—Betamethasone—ankylosing spondylitis	0.00037	0.0135	CcSEcCtD
Fluocinonide—Acneiform eruption—Dexamethasone—ankylosing spondylitis	0.00037	0.0135	CcSEcCtD
Fluocinonide—Cushing's syndrome—Prednisone—ankylosing spondylitis	0.000359	0.013	CcSEcCtD
Fluocinonide—Cataract subcapsular—Betamethasone—ankylosing spondylitis	0.000358	0.013	CcSEcCtD
Fluocinonide—Cataract subcapsular—Dexamethasone—ankylosing spondylitis	0.000358	0.013	CcSEcCtD
Fluocinonide—Skin striae—Prednisolone—ankylosing spondylitis	0.000352	0.0128	CcSEcCtD
Fluocinonide—Secondary infection—Triamcinolone—ankylosing spondylitis	0.000351	0.0128	CcSEcCtD
Fluocinonide—Miliaria—Triamcinolone—ankylosing spondylitis	0.000351	0.0128	CcSEcCtD
Fluocinonide—Secondary infection—Methylprednisolone—ankylosing spondylitis	0.00035	0.0127	CcSEcCtD
Fluocinonide—Miliaria—Methylprednisolone—ankylosing spondylitis	0.00035	0.0127	CcSEcCtD
Fluocinonide—Telangiectasia—Prednisone—ankylosing spondylitis	0.000345	0.0126	CcSEcCtD
Fluocinonide—Atrophy—Prednisolone—ankylosing spondylitis	0.000344	0.0125	CcSEcCtD
Fluocinonide—Skin atrophy—Triamcinolone—ankylosing spondylitis	0.000341	0.0124	CcSEcCtD
Fluocinonide—Skin atrophy—Methylprednisolone—ankylosing spondylitis	0.00034	0.0124	CcSEcCtD
Fluocinonide—Skin striae—Triamcinolone—ankylosing spondylitis	0.000324	0.0118	CcSEcCtD
Fluocinonide—Skin striae—Methylprednisolone—ankylosing spondylitis	0.000323	0.0118	CcSEcCtD
Fluocinonide—Acneiform eruption—Prednisone—ankylosing spondylitis	0.000322	0.0117	CcSEcCtD
Fluocinonide—Secondary infection—Betamethasone—ankylosing spondylitis	0.000318	0.0116	CcSEcCtD
Fluocinonide—Secondary infection—Dexamethasone—ankylosing spondylitis	0.000318	0.0116	CcSEcCtD
Fluocinonide—Miliaria—Dexamethasone—ankylosing spondylitis	0.000318	0.0116	CcSEcCtD
Fluocinonide—Miliaria—Betamethasone—ankylosing spondylitis	0.000318	0.0116	CcSEcCtD
Fluocinonide—Atrophy—Triamcinolone—ankylosing spondylitis	0.000316	0.0115	CcSEcCtD
Fluocinonide—Atrophy—Methylprednisolone—ankylosing spondylitis	0.000315	0.0115	CcSEcCtD
Fluocinonide—Cataract subcapsular—Prednisone—ankylosing spondylitis	0.000312	0.0113	CcSEcCtD
Fluocinonide—Skin atrophy—Betamethasone—ankylosing spondylitis	0.00031	0.0113	CcSEcCtD
Fluocinonide—Skin atrophy—Dexamethasone—ankylosing spondylitis	0.00031	0.0113	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Triamcinolone—ankylosing spondylitis	0.000302	0.011	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Methylprednisolone—ankylosing spondylitis	0.000301	0.0109	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Triamcinolone—ankylosing spondylitis	0.000295	0.0107	CcSEcCtD
Fluocinonide—Skin striae—Dexamethasone—ankylosing spondylitis	0.000294	0.0107	CcSEcCtD
Fluocinonide—Skin striae—Betamethasone—ankylosing spondylitis	0.000294	0.0107	CcSEcCtD
Fluocinonide—Telangiectasia—Methotrexate—ankylosing spondylitis	0.000289	0.0105	CcSEcCtD
Fluocinonide—Atrophy—Dexamethasone—ankylosing spondylitis	0.000287	0.0104	CcSEcCtD
Fluocinonide—Atrophy—Betamethasone—ankylosing spondylitis	0.000287	0.0104	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Dexamethasone—ankylosing spondylitis	0.000274	0.00995	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Betamethasone—ankylosing spondylitis	0.000274	0.00995	CcSEcCtD
Fluocinonide—Hypertrichosis—Triamcinolone—ankylosing spondylitis	0.000271	0.00986	CcSEcCtD
Fluocinonide—Hypertrichosis—Methylprednisolone—ankylosing spondylitis	0.00027	0.00984	CcSEcCtD
Fluocinonide—Skin atrophy—Prednisone—ankylosing spondylitis	0.00027	0.00981	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Dexamethasone—ankylosing spondylitis	0.000268	0.00973	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Betamethasone—ankylosing spondylitis	0.000268	0.00973	CcSEcCtD
Fluocinonide—Leukoderma—Prednisolone—ankylosing spondylitis	0.000264	0.00959	CcSEcCtD
Fluocinonide—Skin striae—Prednisone—ankylosing spondylitis	0.000256	0.00931	CcSEcCtD
Fluocinonide—Atrophy—Prednisone—ankylosing spondylitis	0.00025	0.00909	CcSEcCtD
Fluocinonide—Hypertrichosis—Dexamethasone—ankylosing spondylitis	0.000246	0.00895	CcSEcCtD
Fluocinonide—Hypertrichosis—Betamethasone—ankylosing spondylitis	0.000246	0.00895	CcSEcCtD
Fluocinonide—Leukoderma—Triamcinolone—ankylosing spondylitis	0.000242	0.00882	CcSEcCtD
Fluocinonide—Leukoderma—Methylprednisolone—ankylosing spondylitis	0.000242	0.0088	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Prednisone—ankylosing spondylitis	0.000238	0.00867	CcSEcCtD
Fluocinonide—Leukoderma—Dexamethasone—ankylosing spondylitis	0.00022	0.008	CcSEcCtD
Fluocinonide—Leukoderma—Betamethasone—ankylosing spondylitis	0.00022	0.008	CcSEcCtD
Fluocinonide—Application site reaction—Triamcinolone—ankylosing spondylitis	0.00022	0.00799	CcSEcCtD
Fluocinonide—Hypertrichosis—Prednisone—ankylosing spondylitis	0.000214	0.00779	CcSEcCtD
Fluocinonide—Leukoderma—Prednisone—ankylosing spondylitis	0.000191	0.00697	CcSEcCtD
Fluocinonide—Folliculitis—Triamcinolone—ankylosing spondylitis	0.000164	0.00596	CcSEcCtD
Fluocinonide—Folliculitis—Methylprednisolone—ankylosing spondylitis	0.000164	0.00595	CcSEcCtD
Fluocinonide—Leukoderma—Methotrexate—ankylosing spondylitis	0.00016	0.00582	CcSEcCtD
Fluocinonide—Folliculitis—Betamethasone—ankylosing spondylitis	0.000149	0.00541	CcSEcCtD
Fluocinonide—Folliculitis—Dexamethasone—ankylosing spondylitis	0.000149	0.00541	CcSEcCtD
Fluocinonide—Glycosuria—Triamcinolone—ankylosing spondylitis	0.000127	0.00463	CcSEcCtD
Fluocinonide—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.000127	0.00462	CcSEcCtD
Fluocinonide—Glycosuria—Betamethasone—ankylosing spondylitis	0.000115	0.0042	CcSEcCtD
Fluocinonide—Glycosuria—Dexamethasone—ankylosing spondylitis	0.000115	0.0042	CcSEcCtD
Fluocinonide—Eruption—Methotrexate—ankylosing spondylitis	0.000111	0.00402	CcSEcCtD
Fluocinonide—Folliculitis—Methotrexate—ankylosing spondylitis	0.000108	0.00394	CcSEcCtD
Fluocinonide—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.000102	0.0037	CcSEcCtD
Fluocinonide—Glycosuria—Prednisone—ankylosing spondylitis	0.0001	0.00366	CcSEcCtD
Fluocinonide—Skin exfoliation—Triamcinolone—ankylosing spondylitis	9.84e-05	0.00358	CcSEcCtD
Fluocinonide—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	9.81e-05	0.00357	CcSEcCtD
Fluocinonide—Dermatitis contact—Dexamethasone—ankylosing spondylitis	9.24e-05	0.00336	CcSEcCtD
Fluocinonide—Dermatitis contact—Betamethasone—ankylosing spondylitis	9.24e-05	0.00336	CcSEcCtD
Fluocinonide—Skin exfoliation—Betamethasone—ankylosing spondylitis	8.92e-05	0.00325	CcSEcCtD
Fluocinonide—Skin exfoliation—Dexamethasone—ankylosing spondylitis	8.92e-05	0.00325	CcSEcCtD
Fluocinonide—Skin exfoliation—Prednisone—ankylosing spondylitis	7.77e-05	0.00283	CcSEcCtD
Fluocinonide—Dry skin—Prednisolone—ankylosing spondylitis	7.45e-05	0.00271	CcSEcCtD
Fluocinonide—Skin exfoliation—Methotrexate—ankylosing spondylitis	6.49e-05	0.00236	CcSEcCtD
Fluocinonide—Dry skin—Betamethasone—ankylosing spondylitis	6.22e-05	0.00226	CcSEcCtD
Fluocinonide—Dry skin—Dexamethasone—ankylosing spondylitis	6.22e-05	0.00226	CcSEcCtD
Fluocinonide—Dry skin—Prednisone—ankylosing spondylitis	5.42e-05	0.00197	CcSEcCtD
Fluocinonide—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	5.29e-05	0.00192	CcSEcCtD
Fluocinonide—Hyperglycaemia—Betamethasone—ankylosing spondylitis	5.29e-05	0.00192	CcSEcCtD
Fluocinonide—Erythema—Prednisolone—ankylosing spondylitis	4.9e-05	0.00178	CcSEcCtD
Fluocinonide—Immune system disorder—Methylprednisolone—ankylosing spondylitis	4.66e-05	0.0017	CcSEcCtD
Fluocinonide—Hyperglycaemia—Prednisone—ankylosing spondylitis	4.61e-05	0.00168	CcSEcCtD
Fluocinonide—Erythema—Triamcinolone—ankylosing spondylitis	4.5e-05	0.00164	CcSEcCtD
Fluocinonide—Erythema—Methylprednisolone—ankylosing spondylitis	4.49e-05	0.00163	CcSEcCtD
Fluocinonide—Erythema—Betamethasone—ankylosing spondylitis	4.09e-05	0.00149	CcSEcCtD
Fluocinonide—Erythema—Dexamethasone—ankylosing spondylitis	4.09e-05	0.00149	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	3.8e-05	0.00138	CcSEcCtD
Fluocinonide—Immune system disorder—Prednisone—ankylosing spondylitis	3.69e-05	0.00134	CcSEcCtD
Fluocinonide—Infection—Triamcinolone—ankylosing spondylitis	3.65e-05	0.00133	CcSEcCtD
Fluocinonide—Infection—Methylprednisolone—ankylosing spondylitis	3.64e-05	0.00133	CcSEcCtD
Fluocinonide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	3.6e-05	0.00131	CcSEcCtD
Fluocinonide—Skin disorder—Methylprednisolone—ankylosing spondylitis	3.56e-05	0.0013	CcSEcCtD
Fluocinonide—Erythema—Prednisone—ankylosing spondylitis	3.56e-05	0.00129	CcSEcCtD
Fluocinonide—Pain—Prednisolone—ankylosing spondylitis	3.42e-05	0.00124	CcSEcCtD
Fluocinonide—Infection—Dexamethasone—ankylosing spondylitis	3.31e-05	0.00121	CcSEcCtD
Fluocinonide—Infection—Betamethasone—ankylosing spondylitis	3.31e-05	0.00121	CcSEcCtD
Fluocinonide—Nervous system disorder—Betamethasone—ankylosing spondylitis	3.27e-05	0.00119	CcSEcCtD
Fluocinonide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	3.27e-05	0.00119	CcSEcCtD
Fluocinonide—Pain—Triamcinolone—ankylosing spondylitis	3.14e-05	0.00114	CcSEcCtD
Fluocinonide—Immune system disorder—Methotrexate—ankylosing spondylitis	3.09e-05	0.00112	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	3.01e-05	0.00109	CcSEcCtD
Fluocinonide—Erythema—Methotrexate—ankylosing spondylitis	2.97e-05	0.00108	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.94e-05	0.00107	CcSEcCtD
Fluocinonide—Infection—Prednisone—ankylosing spondylitis	2.89e-05	0.00105	CcSEcCtD
Fluocinonide—Pain—Dexamethasone—ankylosing spondylitis	2.85e-05	0.00104	CcSEcCtD
Fluocinonide—Pain—Betamethasone—ankylosing spondylitis	2.85e-05	0.00104	CcSEcCtD
Fluocinonide—Nervous system disorder—Prednisone—ankylosing spondylitis	2.85e-05	0.00104	CcSEcCtD
Fluocinonide—Skin disorder—Prednisone—ankylosing spondylitis	2.82e-05	0.00103	CcSEcCtD
Fluocinonide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.71e-05	0.000985	CcSEcCtD
Fluocinonide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.7e-05	0.000983	CcSEcCtD
Fluocinonide—Dizziness—Prednisolone—ankylosing spondylitis	2.64e-05	0.000961	CcSEcCtD
Fluocinonide—Pruritus—Triamcinolone—ankylosing spondylitis	2.6e-05	0.000946	CcSEcCtD
Fluocinonide—Pruritus—Methylprednisolone—ankylosing spondylitis	2.59e-05	0.000944	CcSEcCtD
Fluocinonide—Rash—Prednisolone—ankylosing spondylitis	2.52e-05	0.000917	CcSEcCtD
Fluocinonide—Dermatitis—Prednisolone—ankylosing spondylitis	2.52e-05	0.000916	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.51e-05	0.000915	CcSEcCtD
Fluocinonide—Headache—Prednisolone—ankylosing spondylitis	2.5e-05	0.000911	CcSEcCtD
Fluocinonide—Dizziness—Triamcinolone—ankylosing spondylitis	2.43e-05	0.000884	CcSEcCtD
Fluocinonide—Dizziness—Methylprednisolone—ankylosing spondylitis	2.43e-05	0.000882	CcSEcCtD
Fluocinonide—Infection—Methotrexate—ankylosing spondylitis	2.41e-05	0.000877	CcSEcCtD
Fluocinonide—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.38e-05	0.000866	CcSEcCtD
Fluocinonide—Pruritus—Dexamethasone—ankylosing spondylitis	2.36e-05	0.000858	CcSEcCtD
Fluocinonide—Pruritus—Betamethasone—ankylosing spondylitis	2.36e-05	0.000858	CcSEcCtD
Fluocinonide—Skin disorder—Methotrexate—ankylosing spondylitis	2.36e-05	0.000858	CcSEcCtD
Fluocinonide—Rash—Triamcinolone—ankylosing spondylitis	2.32e-05	0.000843	CcSEcCtD
Fluocinonide—Dermatitis—Triamcinolone—ankylosing spondylitis	2.32e-05	0.000842	CcSEcCtD
Fluocinonide—Rash—Methylprednisolone—ankylosing spondylitis	2.31e-05	0.000841	CcSEcCtD
Fluocinonide—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.31e-05	0.00084	CcSEcCtD
Fluocinonide—Headache—Triamcinolone—ankylosing spondylitis	2.3e-05	0.000838	CcSEcCtD
Fluocinonide—Headache—Methylprednisolone—ankylosing spondylitis	2.3e-05	0.000836	CcSEcCtD
Fluocinonide—Dizziness—Dexamethasone—ankylosing spondylitis	2.21e-05	0.000802	CcSEcCtD
Fluocinonide—Dizziness—Betamethasone—ankylosing spondylitis	2.21e-05	0.000802	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisone—ankylosing spondylitis	2.14e-05	0.000778	CcSEcCtD
Fluocinonide—Rash—Dexamethasone—ankylosing spondylitis	2.1e-05	0.000765	CcSEcCtD
Fluocinonide—Rash—Betamethasone—ankylosing spondylitis	2.1e-05	0.000765	CcSEcCtD
Fluocinonide—Dermatitis—Betamethasone—ankylosing spondylitis	2.1e-05	0.000764	CcSEcCtD
Fluocinonide—Dermatitis—Dexamethasone—ankylosing spondylitis	2.1e-05	0.000764	CcSEcCtD
Fluocinonide—Headache—Betamethasone—ankylosing spondylitis	2.09e-05	0.00076	CcSEcCtD
Fluocinonide—Headache—Dexamethasone—ankylosing spondylitis	2.09e-05	0.00076	CcSEcCtD
Fluocinonide—Pain—Methotrexate—ankylosing spondylitis	2.08e-05	0.000755	CcSEcCtD
Fluocinonide—Pruritus—Prednisone—ankylosing spondylitis	2.05e-05	0.000748	CcSEcCtD
Fluocinonide—Dizziness—Prednisone—ankylosing spondylitis	1.92e-05	0.000699	CcSEcCtD
Fluocinonide—Rash—Prednisone—ankylosing spondylitis	1.83e-05	0.000666	CcSEcCtD
Fluocinonide—Dermatitis—Prednisone—ankylosing spondylitis	1.83e-05	0.000666	CcSEcCtD
Fluocinonide—Headache—Prednisone—ankylosing spondylitis	1.82e-05	0.000662	CcSEcCtD
Fluocinonide—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.79e-05	0.000651	CcSEcCtD
Fluocinonide—Pruritus—Methotrexate—ankylosing spondylitis	1.72e-05	0.000625	CcSEcCtD
Fluocinonide—Dizziness—Methotrexate—ankylosing spondylitis	1.61e-05	0.000584	CcSEcCtD
Fluocinonide—Rash—Methotrexate—ankylosing spondylitis	1.53e-05	0.000557	CcSEcCtD
Fluocinonide—Dermatitis—Methotrexate—ankylosing spondylitis	1.53e-05	0.000556	CcSEcCtD
Fluocinonide—Headache—Methotrexate—ankylosing spondylitis	1.52e-05	0.000553	CcSEcCtD
